The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of rectal cancer patients treated using Polish II neoadjuvant short course radiation therapy and chemotherapy approach in comprehensive cancer center.
 
Stephen Haff
No Relationships to Disclose
 
Syed Mohammad Ali Kazmi
No Relationships to Disclose
 
Nina Niu Sanford
No Relationships to Disclose
 
Todd Anthony Aguilera
No Relationships to Disclose
 
Muhammad Shaalan Beg
Consulting or Advisory Role - Array BioPharma; Boston Biomedical; Ipsen
Speakers' Bureau - Bristol-Myers Squibb; Ipsen
Research Funding - Agios (Inst); ArQule (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); CASI Pharmaceuticals (Inst); Celgene (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); ImmuneSensor Therapeutics (Inst); MedImmune (Inst); Merck Serono (Inst); Sillajen (Inst); Tolero Pharmaceuticals (Inst)
 
Linda Farkas
No Relationships to Disclose
 
Joselin Anandam-Matthews
No Relationships to Disclose
 
Javier Salgado Pogacnik
No Relationships to Disclose
 
Naga Cheedella
No Relationships to Disclose
 
Sirisha Karri
Employment - The Permante Medical Group
Travel, Accommodations, Expenses - The Permante Medical Group
 
Radhika Kainthla
No Relationships to Disclose
 
Amy Little Jones
No Relationships to Disclose
 
Udit Verma
No Relationships to Disclose
 
Aravind Sanjeevaiah
Travel, Accommodations, Expenses - NanoCarrier
 
Michael Ryan Folkert
Research Funding - Boston Scientific (Inst)
Travel, Accommodations, Expenses - Boston Scientific; Boston Scientific